| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_282d8844066f5f683bc2463742373508
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4b8e71233d46c313ac971fc4f9e4aa4d |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02A50-30 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-55
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-5517
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-6889
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-6849
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D487-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-6803 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-5517
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-55
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D487-04 |
| filingDate |
2012-10-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e525666030144e6c424abb2e6a15c2ba
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3fc286d37065ac96be20e1160f5b17ff
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3f264261576a5bffd7899a89a3c94043 |
| publicationDate |
2018-10-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-3388435-A1 |
| titleOfInvention |
Pyrrolobenzodiazepines and targeted conjugates |
| abstract |
A Conjugate having formula IV: nL - (LU-D) P (IV) nor a pharmaceutically acceptable salt or solvate thereof; wherein L is a Ligand Unit selected from the group consisting of an antibody and an antigen-binding fragment of an antibody, LU is a Linker Unit, p is 1 to 20; and D is selected from the group consisting of D1 to D6 having the structures as defined in claim 1 and wherein LU is: n n n n nwherein the asterisk indicates the point of attachment to D, the wavy line indicates the point of attachment to the Ligand Unit, Y is NH and E is glucuronic acid; and nA 1 is a Stretcher Unit. |
| priorityDate |
2011-10-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |